Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life
- PMID: 9218082
- DOI: 10.1046/j.1365-2036.1997.00160.x
Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life
Abstract
Aim: In this study of patients with irritable bowel syndrome (IBS), we evaluated the relationship between patient-rated severity of IBS and patients' physical and psychological symptoms, health care resource use and quality of life.
Methods: One hundred and twenty-six patients diagnosed with IBS were administered a series of questionnaires, including the Bowel Symptom Checklist, the Symptom Checklist-90-R (a psychological symptom checklist), the IBSQOL (a disease-specific quality of life instrument), the SF-36 (a general health status instrument), and a health resource utilization assessment that measured health care use, time loss from work, impact on productivity, and days worked with symptoms.
Results: No relationship was found between IBS severity and gastrointestinal symptoms, except for a feeling of unpassed stool. IBS severity was also not related to psychological symptom severity. Direct traditional indicators of resource use (e.g. physician visits, hospital admissions and emergency room visits) were not significantly associated by severity level; however, indirect measures of resource use (e.g. number of days with pain, productivity and number of bed days) were related to severity. Quality of life was clearly associated with perceived IBS severity. Patients who rated themselves as very severe reported the lowest scores and had the poorest health for all quality of life dimensions measured.
Conclusions: These findings suggest that perceived IBS severity is defined by the limitations the disease imposes, rather that by the symptoms. Patients with reduced productivity and decreased functioning for most of the quality of life indicators were those who rated their IBS as very severe.
Similar articles
-
Quality of life in irritable bowel syndrome.Pharmacoeconomics. 2001;19(6):643-53. doi: 10.2165/00019053-200119060-00003. Pharmacoeconomics. 2001. PMID: 11456212 Review.
-
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.Digestion. 1999 Jan-Feb;60(1):77-81. doi: 10.1159/000007593. Digestion. 1999. PMID: 9892803
-
Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.Clin Ther. 2006 Oct;28(10):1726-35; discussion 1710-1. doi: 10.1016/j.clinthera.2006.10.010. Clin Ther. 2006. PMID: 17157129
-
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.Ann Intern Med. 2001 May 1;134(9 Pt 2):860-8. doi: 10.7326/0003-4819-134-9_part_2-200105011-00010. Ann Intern Med. 2001. PMID: 11346322
-
Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.Qual Life Res. 2000 Mar;9(2):161-76. doi: 10.1023/a:1008970312068. Qual Life Res. 2000. PMID: 10983480 Review.
Cited by
-
Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.Am Health Drug Benefits. 2014 Aug;7(5):289-97. Am Health Drug Benefits. 2014. PMID: 25237424 Free PMC article.
-
Economic effects of introducing alternative Salmonella control strategies in Sweden.PLoS One. 2014 May 15;9(5):e96446. doi: 10.1371/journal.pone.0096446. eCollection 2014. PLoS One. 2014. PMID: 24831797 Free PMC article.
-
Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway.Health Qual Life Outcomes. 2015 Jul 30;13:113. doi: 10.1186/s12955-015-0311-8. Health Qual Life Outcomes. 2015. PMID: 26223784 Free PMC article.
-
Quality of life in irritable bowel syndrome.Pharmacoeconomics. 2001;19(6):643-53. doi: 10.2165/00019053-200119060-00003. Pharmacoeconomics. 2001. PMID: 11456212 Review.
-
Irritable bowel syndrome: Factors of importance for disease-specific quality of life.United European Gastroenterol J. 2022 Sep;10(7):754-764. doi: 10.1002/ueg2.12277. Epub 2022 Jul 13. United European Gastroenterol J. 2022. PMID: 35830193 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical